Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2015

01.12.2015 | Original Research Article

In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device

verfasst von: Felipe Piacentini Paes de Almeida, Juliana Barbosa Saliba, Jefferson Augusto Santana Ribeiro, Rubens Camargo Siqueira, Sílvia L. Fialho, Armando Silva-Cunha, Rodrigo Jorge, Andre Messias

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the in vivo release profile and retinal safety of cyclosporine A (CsA) delivered from a biodegradable poly-lactide-co-glycolide (PLGA) device in the vitreous cavity of rabbits’ eyes.

Methods

A total of 60 animals (60 eyes) divided into two groups were used. For the in vivo release study, 32 eyes received PLGA implants containing 350 µg of CsA, and 16 eyes received the implants without drug (control). Four animals of CsA group and two of the control group were killed weekly until 8 weeks; the vitreous was removed, and CsA concentration was evaluated. Ophthalmological examination was performed in the animals prior to implant placement and weekly during the study period. Electroretinography (ERG) was performed in other six animals for each group, treated and control, at the beginning and at the end of the study (8 weeks) when they were killed and had their eyes processed for histology.

Results

No sign of inflammation was noticed on slit lamp examinations and the IOP maintained stable during the study period in CsA and control groups. CsA concentration in the vitreous (ng/ml) was 257.07 ± 117.23, 271.15 ± 98.96, 296.66 ± 86.25, 256.27 ± 99.22, 304.50 ± 88.18, 326.35 ± 105.24, 491.25 ± 119.90 and 589.93 ± 132.55 after 1, 2, 3, 4, 5, 6, 7 and 8 weeks of implantation, respectively. At the end of the study, 21.67 % of mass loss was found. The retina did not show any histological alteration in either group, but a significant reduction in dark-adapted b-wave amplitude was observed in the CsA group, with no changes in a-wave amplitude.

Conclusions

These data show that the PLGA system is safe, but the selective reduction in ERG b-wave amplitude indicates that the PLGA with 350 µg CsA causes retinal function impairment, specifically on the rod postreceptor pathway, 8 weeks after implantation. These ERG changes were not associated with any histological damage as seen at the light microscopy level.
Literatur
1.
Zurück zum Zitat BenEzra D, Maftzir G (1990) Ocular penetration of cyclosporin A: the rabbit eye. Invest Ophthalmol Vis Sci 31:1362–1366PubMed BenEzra D, Maftzir G (1990) Ocular penetration of cyclosporin A: the rabbit eye. Invest Ophthalmol Vis Sci 31:1362–1366PubMed
2.
Zurück zum Zitat Nussenblatt RB, Dinning WJ, Fujikawa LS, Chan CC, Palestine AG (1985) Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol 103:1559–1562CrossRefPubMed Nussenblatt RB, Dinning WJ, Fujikawa LS, Chan CC, Palestine AG (1985) Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol 103:1559–1562CrossRefPubMed
3.
Zurück zum Zitat Alghadyan AA, Peyman GA, Khoobehi B, Liu KR (1988) Liposome-bound cyclosporine: retinal toxicity after intravitreal injection. Int Ophthalmol 12:105–107CrossRefPubMed Alghadyan AA, Peyman GA, Khoobehi B, Liu KR (1988) Liposome-bound cyclosporine: retinal toxicity after intravitreal injection. Int Ophthalmol 12:105–107CrossRefPubMed
4.
Zurück zum Zitat Saliba JBFA, Yoshida MI, Vasconcelos WL, Silva-Cunha A, Mansur HS (2008) Development and characterization of an intraocular biodegradable polymer system containing cyclosporine-A for the treatment of posterior uveitis. Mater Res 11:207–211CrossRef Saliba JBFA, Yoshida MI, Vasconcelos WL, Silva-Cunha A, Mansur HS (2008) Development and characterization of an intraocular biodegradable polymer system containing cyclosporine-A for the treatment of posterior uveitis. Mater Res 11:207–211CrossRef
5.
Zurück zum Zitat Saliba JBC-J, Gomes EA, Mansur HS, Silva GR (2011) Development and validation of a high performance liquid chromatographic method for determination of cyclosporine-a from biodegradable intraocular implants. Quim Nova 34:140–144CrossRef Saliba JBC-J, Gomes EA, Mansur HS, Silva GR (2011) Development and validation of a high performance liquid chromatographic method for determination of cyclosporine-a from biodegradable intraocular implants. Quim Nova 34:140–144CrossRef
6.
Zurück zum Zitat Yasukawa T, Kimura H, Tabata Y, Ogura Y (2001) Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev 52:25–36CrossRefPubMed Yasukawa T, Kimura H, Tabata Y, Ogura Y (2001) Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev 52:25–36CrossRefPubMed
7.
Zurück zum Zitat Lee SS, Hughes P, Ross AD, Robinson MR (2010) Biodegradable implants for sustained drug release in the eye. Pharm Res 27:2043–2053CrossRefPubMed Lee SS, Hughes P, Ross AD, Robinson MR (2010) Biodegradable implants for sustained drug release in the eye. Pharm Res 27:2043–2053CrossRefPubMed
8.
Zurück zum Zitat Dong X, Shi W, Yuan G, Xie L, Wang S, Lin P (2006) Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis. Graefes Arch Clin Exp Ophthalmol 244:492–497CrossRefPubMed Dong X, Shi W, Yuan G, Xie L, Wang S, Lin P (2006) Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis. Graefes Arch Clin Exp Ophthalmol 244:492–497CrossRefPubMed
9.
Zurück zum Zitat He Y, Wang JC, Liu YL, Ma ZZ, Zhu XA, Zhang Q (2006) Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits. J Ocul Pharmacol Ther 22:121–131CrossRefPubMed He Y, Wang JC, Liu YL, Ma ZZ, Zhu XA, Zhang Q (2006) Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits. J Ocul Pharmacol Ther 22:121–131CrossRefPubMed
10.
Zurück zum Zitat Gilger BC, Malok E, Stewart T, Horohov D, Ashton P, Smith T, Jaffe GJ, Allen JB (2000) Effect of an intravitreal cyclosporine implant on experimental uveitis in horses. Vet Immunol Immunopathol 76:239–255CrossRefPubMed Gilger BC, Malok E, Stewart T, Horohov D, Ashton P, Smith T, Jaffe GJ, Allen JB (2000) Effect of an intravitreal cyclosporine implant on experimental uveitis in horses. Vet Immunol Immunopathol 76:239–255CrossRefPubMed
11.
Zurück zum Zitat Laferty K, Borel JF, Hodgkin P (1983) Cyclosporine-A (CsA); models for the mechanism of action. Transplant Proc 15:2242–2247 Laferty K, Borel JF, Hodgkin P (1983) Cyclosporine-A (CsA); models for the mechanism of action. Transplant Proc 15:2242–2247
12.
Zurück zum Zitat Fialho SL, Rego MB, Siqueira RC, Jorge R, Haddad A, Rodrigues AL, Maia-Filho A, Silva-Cunha A (2006) Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes. Curr Eye Res 31:525–534CrossRefPubMed Fialho SL, Rego MB, Siqueira RC, Jorge R, Haddad A, Rodrigues AL, Maia-Filho A, Silva-Cunha A (2006) Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes. Curr Eye Res 31:525–534CrossRefPubMed
13.
Zurück zum Zitat He Y, Liu Y, Wang J, Zhang X, Lu W, Ma Z, Zhu X, Zhang Q (2006) Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study. Invest Ophthalmol Vis Sci 47:3983–3988CrossRefPubMed He Y, Liu Y, Wang J, Zhang X, Lu W, Ma Z, Zhu X, Zhang Q (2006) Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study. Invest Ophthalmol Vis Sci 47:3983–3988CrossRefPubMed
14.
Zurück zum Zitat Pearson PA, Jaffe GJ, Martin DF, Cordahi GJ, Grossniklaus H, Schmeisser ET, Ashton P (1996) Evaluation of a delivery system providing long-term release of cyclosporine. Arch Ophthalmol 114:311–317CrossRefPubMed Pearson PA, Jaffe GJ, Martin DF, Cordahi GJ, Grossniklaus H, Schmeisser ET, Ashton P (1996) Evaluation of a delivery system providing long-term release of cyclosporine. Arch Ophthalmol 114:311–317CrossRefPubMed
15.
Zurück zum Zitat Schubert G, Bornschein H (1952) Analysis of the human electroretinogram. Ophthalmologica 123:396–413CrossRefPubMed Schubert G, Bornschein H (1952) Analysis of the human electroretinogram. Ophthalmologica 123:396–413CrossRefPubMed
16.
Zurück zum Zitat Hirose T, Wolf E, Hara A (1977) Electrophysiological and psychophysical studies in congenital retinoschisis of X-linked recessive inheritance—Electroretinography-clinical correlations. In: Henkes HE (ed) Documenta ophthalmologica proceedings series—ERG, VER and Psychophysics 14th I. S. C. E. R. G. Symposium, volume 13, Dr W. Junk b.v. Publishers, pp 173–184 Hirose T, Wolf E, Hara A (1977) Electrophysiological and psychophysical studies in congenital retinoschisis of X-linked recessive inheritance—Electroretinography-clinical correlations. In: Henkes HE (ed) Documenta ophthalmologica proceedings series—ERG, VER and Psychophysics 14th I. S. C. E. R. G. Symposium, volume 13, Dr W. Junk b.v. Publishers, pp 173–184
17.
Zurück zum Zitat Messias A, Ramos Filho JA, Messias K, Almeida FP, Costa RA, Scott IU, Gekeler F, Jorge R (2012) Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Doc ophthalmol Adv Ophthalmol 124:225–236CrossRef Messias A, Ramos Filho JA, Messias K, Almeida FP, Costa RA, Scott IU, Gekeler F, Jorge R (2012) Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Doc ophthalmol Adv Ophthalmol 124:225–236CrossRef
18.
Zurück zum Zitat Green DG, Kapousta-Bruneau NV (1999) A dissection of the electroretinogram from the isolated rat retina with microelectrodes and drugs. Vis Neurosci 16:727–741CrossRefPubMed Green DG, Kapousta-Bruneau NV (1999) A dissection of the electroretinogram from the isolated rat retina with microelectrodes and drugs. Vis Neurosci 16:727–741CrossRefPubMed
Metadaten
Titel
In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device
verfasst von
Felipe Piacentini Paes de Almeida
Juliana Barbosa Saliba
Jefferson Augusto Santana Ribeiro
Rubens Camargo Siqueira
Sílvia L. Fialho
Armando Silva-Cunha
Rodrigo Jorge
Andre Messias
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2015
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-015-9520-z

Weitere Artikel der Ausgabe 3/2015

Documenta Ophthalmologica 3/2015 Zur Ausgabe

Clinical Case Report

Linezolid induced retinopathy

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.